CIK 0001851484 · <br>Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 994362660
- Phone
- (908) 967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- NT 10-Q Other NT 10-Q
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
Page 10 of 14 · 268 filings